Nyhetsarkiv for Translasjonell kreftforskning
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
- mars 2021 (1)
- oktober 2020 (2)
- april 2020 (1)
- desember 2018 (1)
- november 2018 (1)
- november 2017 (1)
- juli 2016 (1)